The Mouse Defense Test Battery: Evaluation of the effects of non-selective and BZ-1 (ω1) selective, benzodiazepine receptor ligands

Behavioural Pharmacology

Volumn 7, Issue 6, 1996, Pages 560-572

  Griebel, G ^a   Sanger, D J ^a   Perrault, G ^a  

^a SANOFI   (France)

Author keywords

anxiety; benzodiazepines; BZ ( ) receptor; defensive behaviors; flight; Mouse Defense Test Battery; risk assessment; Swiss mice

Indexed keywords

3 METHYL 6 (3 TRIFLUOROMETHYLPHENYL) 1,2,4 TRIAZOLO[4,3 B]PYRIDAZINE; ABECARNIL; BENZODIAZEPINE 1 RECEPTOR; BENZODIAZEPINE RECEPTOR; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; BRETAZENIL; CHLORDIAZEPOXIDE; CLONAZEPAM; CLORAZEPATE; DIAZEPAM; IMIDAZENIL; PARTIAL AGONIST; UNCLASSIFIED DRUG; ZOLPIDEM;

AGGRESSION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; DEFENSIVE BEHAVIOR; DRUG SELECTIVITY; ESCAPE BEHAVIOR; FLIGHT; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; RAT; RISK ASSESSMENT; TECHNIQUE; THREAT;

EID: 0030459224     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Beauclair L, Fontaine R, Annable L, Holobow N and Chouinard G (1994) Clonazepam in the treatment of panic disorder: A double-blind, placebo-controlled trial investigating the correlation between clonazepam concentrations in plasma and clinical response. Journal of Clinical Psychopharmacology, 14, 111-118.
2. Beaudry P, Fontaine R, Chouinard G and Annable L (1985) An open clinical trial of clonazepam in the treatment of patients with recurrent panic attacks. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 9, 589-592.
3. Blanchard DC, Hori K, Rodgers RJ and Hendrie CA (1989) Attenuation of defensive threat and attache in wild rats (Rattus rattus) by benzodiazepines. Psychopharmacology, 97, 392-401.
4. Blanchard RJ, Yudko EB, Rodgers RJ and Blanchard DC (1993) Defense system psychopharmacology: An ethological approach to the pharmacology of fear and anxiety. Behavioural Brain Research, 58, 155-165.
5. Cole JC and Rodgers RJ (1993) An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro 16-6028) in the murine elevated plus-maze. Behavioural Pharmacology, 4, 573-580.
6. A Receptors and Anxiety.(Eds G Biggio, E Sanna, M Serra and E Costa), pp. 75-92. Raven Press, New York.
7. A receptor modulators. Journal of Pharmacology and Experimental Therapeutics, 273, 241-247.
8. Depoortere H, Zivkovic B, Lloyd KG, Sanger DJ, Perrault G, Langer SZ and Bartholini G (1986) Zolpidem, a novel non-benzodiazepine hypnotic: I. Neuropharmacological and behavioral effects. Journal of Pharmacology and Experimental Therapeutics, 237, 649-658.
9. Facklam M, Schoch P and Haefely WE (1992) Relationship between benzodiazepine receptor occupancy and potentiation of gamma-aminobutyric acid-stimulated chloride flux in vitro of four ligands of differing intrinsic efficacies. Journal of Pharmacology and Experimental Therapeutics, 261, 1107-1112.
10. A receptor. European Journal of Pharmacology, 246, 283-287.
11. A receptors. Journal of Pharmacology and Experimental Therapeutics, 266, 1018-1028.
12. Griebel G, Blanchard DC, Jung A and Blanchard RJ (1995a) A model of 'antipredator' defense in Swiss-Webster mice: Effects of benzodiazepine receptor ligands with different intrinsic activities. Behavioral Pharmacology, 6, 732-745.
13. Griebel G, Blanchard DC, Jung A, Lee JC, Masuda CK and Blanchard RJ (1995b) Further evidence that the Mouse Defense Test Battery is useful for screening anxiolytic and panicolytic drugs: Effects of acute and chronic treatment with alprazolam. Neuropharmacology, 34, 1625-1633.
14. Griebel G, Sanger DJ and Perrault G (1996a) The use of the rat elevated plus-maze to discriminate between non-selective and BZ-1 (ω1) selective, benzodiazepine receptor ligands. Psychopharmacology, 124, 245-254.
15. Griebel G, Sanger DJ and Perrault G (1996b) Further evidence for differences between non-selective and BZ-1 (ω1) selective, benzodiazepine receptor ligands in murine models of "state" and "trait" anxiety. Neuropharmacology, (in press).
16. Griebel G, Blanchard DC and Blanchard RJ (1996c) Predator-elicited flight responses in Swiss-Webster mice: an experimental model of panic attacks. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 20, 185-205.
17. Griebel G, Sanger DJ and Perrault G (1996d) Genetic differences in the Mouse Defense Test Battery. Aggressive Behavior, (in press).
18. Haefely W, Martin JR and Schoch P (1990) Novel anxiolytics that acts as partial agonists at benzodiazepine receptors. Trends in Pharmacological Sciences, 11, 452-456.
19. Jenck F, Moreau JL, Bonetti EP, Martin JR and Haefely WE (1992) Ro 19-8022, a nonbenzodiazepine partial agonist at benzodiazepine receptors: neuropharmacological profile of a potential anxiolytic. Journal of Pharmacology and Experimental Therapeutics, 262, 1121-1127.
20. Jones GH, Schneider C, Schneider HH, Seidler J, Cole BJ and Stephens DN (1994) Comparison of several benzodiazepine receptor ligands in two models of anxiolytic activity in the mouse: An analysis based on fractional receptor occupancies. Psychopharmacology, 114, 191-199.
21. A receptor. Journal of Pharmacology and Experimental Therapeutics, 266, 385-391.
22. Langer SZ and Arbilla S (1988) Imidazopyridines as a tool for the characterization of benzodiazepine receptors: a proposal for a pharmacological classification as omega receptor subtypes. Pharmacology, Biochemistry and Behavior, 29, 763-766.
23. Lapierre YD (1983) Are all benzodiazepines clinically equivalent? Progress in Neuro-Psychopharmacology and Biological Psychiatry, 7, 641-646.
24. Martin JR, Schoch P, Jenck F, Moreau J-L and Haefely WE (1993) Pharmacological characterization of benzodiazepine receptor ligands with intrinsic efficacies ranging from high to zero. Psychopharmacology, 111, 415-422.
25. A Receptors and Anxiety: From Neurobiology to Treatment. (Eds G Biggio, E Sanna and E Costa), pp. 41-56. Raven Press, New York.
26. Perrault G, Morel E, Sanger DJ and Zivkovic B (1990) Differences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnotics. European Journal of Pharmacology, 187, 487-494.
27. Potokar J and Nutt DJ (1994) Anxiolytic potential of benzodiazepine receptor partial agonists. CNS Drugs, 1, 305-315.
28. A receptor subtypes. In: Anxiolytic β-carbolines. (Ed. DN Stephens), pp. 50-61. Springer-Verlag, Berlin.
29. A-benzodiazepine receptors produced in transfected cells. Science, 245, 1389-1392.
30. A receptor α5-subunit creates novel type II benzodiazepine receptor pharmacology. Journal of Neurochemistry, 54, 1802-1804.
31. Puia G, Ducic I, Vicini S and Costa E (1992) Molecular mechanisms of the partial allosteric modulatory effects of bretazenil at gamma-aminobutyric acid type A receptor. Proceedings of the National Academy of Sciences USA, 89, 3620-3624.
32. Sanger DJ (1995) The behavioural effects of novel benzodiazepine (CD) receptor agonists and partial agonists: Increases in punished responding and antagonism of the pentylenetetrazole cue. Behavioural Pharmacology, 6, 116-126.
33. Sanger DJ, Benavides J, Perrault G, Morel E, Cohen C, Joly D and Zivkovic B (1994) Recent developments in the behavioral pharmacology of benzodiazepine (ω) receptors: Evidence for the functional significance of receptor subtypes. Neuroscience and Biobehavioral Reviews, 18, 355-372.
34. Sanger DJ, Joly D and Perrault G (1995) Benzodiazepine (ω) receptor partial agonists and the acquisition of conditioned fear in mice. Psychopharmacology, 121, 104-108.
35. A receptor subtypes. Pharmacological Reviews, 47, 181-234.
36. Sieghart W and Schuster A (1984) Affinity of various ligands for benzodiazepine receptors in rat cerebellum and hippocampus. Pharmacology, Biochemistry and Behavior, 33, 4033-4038.
37. Squires RF, Benson DI, Braestrup C, Coupet J, Klepner CA, Myers V and Beer B (1979) Some properties of brain specific benzodiazepine receptors: new evidence for multiple receptors. Pharmacology, Biochemistry and Behavior, 10, 825-830.
38. Svebak S, Cameron A and Levander S (1990) Clonazepam and imipramine in the treatment of panic attacks: a double-blind comparison of efficacy and side-effects. Journal of Clinical Psychiatry, 51, 14-17.
39. Wafford KA, Whiting PJ and Kemp JA (1993) Differences in affinity and efficacy of benzodiazepine receptor ligands at recombinant gamma-aminobutyric acid receptor subtypes. Molecular Pharmacology, 43, 240-244.
40. Witkin JM, Acri JB, Wong G, Gleeson S and Barrett JE (1996) Behavioral and biochemical characterization of benzodiazepine receptor partial agonists in pigeons. Journal of Pharmacology and Experimental Therapeutics, 277, 87-96.